Searchable abstracts of presentations at key conferences in endocrinology

ea0035p598 | Endocrine tumours and neoplasia | ECE2014

Expression of somatostatin and dopamine receptors in neuroendocrine tumors: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores

Diakatou Evanthia , Tsolakis Apostolos , Alexandraki Krystallenia , Chatzellis Eleftherios , Leonti Anastasia , Kontogeorgos Georgios , Kaltsas Gregory

Background: The expression and/or co-expression of somatostatin (sstr1–5) and dopamine (DR) receptors in neuroendocrine tumors (NETS) is of clinical interest as their expression implies that NETS could be treated with combined targeted therapy. In addition, the expression of sstrs permits tumour visualization with radiolabelled sst analogs (111In-DTPA-OctreoScan).Methods: We analyzed preoperative Octreoscans findings (also graded for the ...

ea0035p608 | Endocrine tumours and neoplasia | ECE2014

Metastatic bone disease in patients with neuroendocrine tumors

Alexandraki Krystallenia , Chrysochoou Maria , Kaltsatou Maria , Chatzellis Eleftherios , Tsoli Marina , Boutzios Georgios , Thomas Dimitrios , Kaltsas Gregory

Objective: The prevalence of metastatic bone disease in patients with neuroendocrine tumours (NETs) and their response to first line treatment with biphosphonates.Methods: We studied 271 patients (141 females) with NETs: 54 gastric, nine duodenal, 102 pancreatic, 29 small intestine, 29 appendix, 14 colon, 15 lung, one thymic, 20 unknown primary and ten elsewhere. Since September 2012 all patients with NETs and bone metastases were recruited to receive 4 ...

ea0070ep126 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Augmentation index in the assessment of pulse wave reflection assessment in lean and obese women with polycystic ovary syndrome (PCOS)

Alexandraki Krystallenia , Kandaraki Eleni , Papaioannou Theodoros , Piperi Christina , Argyris Antonis , Papamichael Christos , Protogerou Athnasios , Lekakis John

Objective: Conflicting findings have been published regarding the pressure wave reflection and the arterial stiffness in young women with PCOS as opposed to the overt ab initio presence of endothelial dysfunction compared with controls which can be reversed six months after metformin administration. The aim of this study was to investigate arterial stiffness and wave reflections in young women with polycystic ovary syndrome (PCOS) with respects to the different weight...

ea0081p256 | Late-Breaking | ECE2022

Hobnail variant of papillary thyroid carcinoma, a systematic review and meta-analysis

Spyroglou Ariadni , Kostopoulos George , Bramis Konstantinos , Tseleni Sofia , Toulis Konstantinos , Mastorakos George , Konstadoulakis Manousos , Vamvakidis Kyriakos , Alexandraki Krystallenia

Background: Although papillary thyroid carcinoma (PTC) is considered to have an excellent prognosis, some more aggressive variants have been identified that show reduced overall survival rates. Besides from the diffuse sclerosing, tall cell, columnar cell, and solid variant, the hobnail variant was newly recognized as one of these aggressive forms, affecting recurrence, metastasis, and overall survival rates.Methods: We performed a systematic review and ...

ea0041gp23 | Adrenal (2) | ECE2016

Deterioration of indices of insulin resistance in patients with non-functioning and cortisol secreting adrenal incidentalomas during a long term follow-up

Papanastasiou Labrini , Alexandraki Krystallenia , Fountoulakis Stelios , Kounadi Theodora , Markou Athina , Tsiavos Vaios , Androulakis Ioannis , Samara Christianna , Piaditis George , Kaltsas Gregory

Introduction: Adrenal incidentalomas (AI) with or without concomitant autonomous cortisol secretion can be associated with several metabolic alterations that may lead to increased cardiovascular risk. However, data regarding insulin resistance (IR) during long term follow-up of AI are scarce. The aim was to prospectively investigate the presence and evolution of IR in patients with AI between 2003 and 2014.Methods: Seventy three patients with AI for at l...

ea0041ep633 | Endocrine tumours and neoplasia | ECE2016

Mechano growth factor (MGF) expression increased in secondary compared to primary foci in well neuroendocrine neoplasms

Alexandraki Krystallenia , Philippou Anastasios , Boutzios Georgios , Moschouris Panagiotis , Karnezis James , Theohari Irini , Koutsilieris Michael , Delladetsima Ioanna , Kaltsas Gregory

Introduction: Insulin-like growth factor-I (IGF-I) has a role in cell proliferation, differentiation, migration, and survival. By alternative splicing different IGF-I mRNA transcripts as IGF-IEc (mechano growth factor, MGF) or IGF-IEa variants are produced. MGF induces muscle hypertrophy and implicated in the pathophysiology of various types of cancer. Aim of the study was to investigate the role of MGF in the pathophysiology of neuroendocrine neoplasms (NENs).<p class="ab...

ea0037ep373 | Diabetes (pathiophysiology &amp; epitemiology) | ECE2015

Higher glucose levels and prevalence of prediabetes in patients with autoimmune thyroiditis

Boutzios Georgios , Alexandraki Krystallenia , Liatis Stavros , Lampropoulou Eleni , Nikolopoulos Georgios , Bouki Aikaterini , Papaoiconomou Eleni , Paradeisi Kokkona , Tentolouris Nikolaos , Kaltsas Gregory

Introduction: Thyroid autoimmunity and diabetes mellitus type 2 (DM2) are the commonest endocrine disorders in the general population. The aim of the study was to investigate whether there is an association between thyroid autoimmunity and β-cell secretion in patients with impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT).Methods/design: 501 patients (381 females) 46.5±14.2 years with IFG and/or IGT and autoimmune thyroidit...

ea0037ep697 | Pituitary: basic and neuroendocrinology | ECE2015

Patients with neuroendocrine neoplasms: the experience of a referral centre in Greece

Alexandraki Krystallenia , Boutzios Georgios , Chatzellis Eleftherios , Thomas Dimitrios , Chrysochoou Maria , Tsoli Marina , Kaltsatou Maria , Nikolopoulos Georgios , Moschouris Panagiotis , Kaltsas Gregory

Introduction: Neuroendocrine neoplasms (NENs) are rare and heterogeneous neoplasms with variable biological behaviour but generally slow progression.Methods/design: 355 patients with NENs registered in our data-base have been studied (166 females, mean age: 52 years; range: 11–88), during the period 2004–2014. TNM system has been used for staging and proliferation index Ki-67 for grading.Results: Out of 355 patients, 35 (...

ea0037ep754 | Pituitary: clinical | ECE2015

Optic neuropathy following radiotherapy for Cushing's disease followed by the diagnosis of pituitary carcinoma

Alexandraki Krystallenia , Boutzios Georgios , Nikolopoulos Georgios , Roussaki Panagoula , Chrysochoou Maria , Chatzellis Eleftherios , Tsoli Marina , Kaltsatou Maria , Moschouris Panagiotis , Kaltsas Gregory

Introduction: ACTH-secreting pituitary carcinomas are rare neoplasms but there are not factors till now to predict their aggressive evolution nor a standard practice to their management.Case report: We report a 43-year-old female patient presented in 1990 with Cushing’s syndrome due to ACTH-secreting pituitary microadenoma who had been submitted on trans-sphenoidal surgery with cure as defined by post-operative cortisol serum levels <50 nmol/l. ...

ea0037ep1146 | Endocrine tumours | ECE2015

Patients with multiple endocrine neoplasia type 1 (MEN1) have late progression and long survival despite the presence of disseminated disease: the experience of a referral centre in Greece

Boutzios Georgios , Alexandraki Krystallenia , Chatzellis Eleftherios , Chrysochoou Maria , Tsoli Marina , Kaltsatou Maria , Nikolopoulos Georgios , Moschouris Panagiotis , Kaltsas Gregory

Introduction: Multiple endocrine neoplasia type 1 (MEN1) is a genetic disorder involving mainly parathyroid tumours, pancreatic neuroendocrine neoplasms (pNENs) and pituitary tumours. In the present study we have registered demographic, clinical, imaging, pathological characteristics, therapeutic options, response to treatment and overall outcome of patients with MEN1.Methods/design: 35 patients with MEN1 registered in our data base have been studied (14...